Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Brand-name Wegovy (semaglutide injection) can exceed $1,400 per month before insurance, making it financially out of reach for many individuals seeking weight loss support. PlexusDx provides a clinically equivalent alternative—compounded semaglutide from licensed 503A pharmacies—at significantly lower cost, with the option to add genetic testing to personalize your therapy pathway.

Understanding Wegovy Injection Pricing and Out-of-Pocket Costs

Brand-name Wegovy pricing fluctuates based on pharmacy location, insurance status, and dosage tier. Patients without insurance coverage typically face monthly costs between $900 and $1,500, even with manufacturer discount programs. Many insurance plans require prior authorization or classify Wegovy as non-covered for weight management, leaving patients responsible for the full branded price.

The cost structure of Wegovy reflects years of pharmaceutical development, clinical trials, and regulatory approval—expenses that are built into the final price tag. However, the active pharmaceutical ingredient (semaglutide) has been available in compounded form through licensed pharmacies since 2022, offering an evidence-based alternative at a fraction of the brand cost.

Without insurance, patients choosing Wegovy often need to budget $10,000 to $18,000 annually for treatment, which may not fit sustained weight loss plans that typically require 6 to 12 months of continuous therapy.

How PlexusDx Compounded Medications Compare in Price and Access

PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A compounding pharmacies—a cost reduction of 80% or more compared to branded Wegovy. The pricing model remains flat regardless of dose escalation, meaning your dose may need to go up, but your price won't. This predictability allows patients to plan long-term weight management without fear of escalating monthly bills.

All PlexusDx medications are available across all 50 states without insurance requirements or membership fees, making treatment accessible to individuals who lack coverage or prefer self-pay options. Patients can apply HSA or FSA funds to treatment, reducing out-of-pocket expenses further. Licensed 503A compounding ensures pharmaceutical-grade quality, sterility, and potency matching brand standards.

Beyond semaglutide, PlexusDx provides tirzepatide (a dual GLP-1/GIP receptor agonist) starting at $249 per month injected, oral formulations, and combination therapies like GLP-Squared (semaglutide plus tirzepatide) beginning at $249 per month—all priced flat across dose tiers.

The Role of Genetic Testing in Personalizing Your Weight Loss Protocol

Not all patients respond equally to GLP-1 therapy, and genetic variation in appetite-regulation pathways explains much of this difference. PlexusDx Precision Peptide Genetic Test identifies key genetic variants—including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—that influence how your body processes peptide signaling and responds to weight loss medications. This test costs only $99 as an add-on after your first month of treatment, making personalization affordable.

The Precision Peptide Genetic Test maps 14 biological pathways, analyzes 49 peptides, and generates 150+ genetic insights specific to your metabolism. Understanding your genetic predispositions allows PlexusDx clinicians to select the optimal compound (semaglutide alone, tirzepatide alone, or dual therapy) and predict potential dose response before committing months to a sub-optimal regimen. This targeted approach maximizes efficacy while minimizing trial-and-error medication changes.

Patients who discover through genetic testing that they carry variants associated with stronger GLP1R responsiveness, for example, may achieve their weight loss goals faster on semaglutide than on other agents—saving time and reducing total treatment costs over months.

Calculating True Value: Total Cost of Care Over 12 Months

A patient choosing Wegovy at $1,200 per month will spend $14,400 over one year without genetic optimization or medication adjustment flexibility. The same patient using PlexusDx compounded semaglutide at $149 per month spends $1,788 annually—a savings of $12,612—plus an optional $99 genetic test yields $1,887 total for 12 months of personalized, genetically informed care. This cost difference often determines whether patients can sustain treatment long enough to reach their weight loss targets.

Value extends beyond price alone: PlexusDx provides nationwide access without insurance hassle, HSA/FSA eligibility, clinical support from licensed pharmacies, and the option to switch compounds or adjust protocols based on individual response—all within the same flat-rate pricing structure. Patients who might abandon expensive branded therapy after three months due to cost can now afford 12-month, evidence-based weight management programs.

When accounting for cardiovascular benefits, metabolic improvements, and reduced weight-related complications, the long-term cost-per-outcome of personalized compounded GLP-1 therapy often surpasses costly branded alternatives, even before genetic optimization.

Transparency and What to Expect From PlexusDx Pricing

PlexusDx commits to transparent, flat-rate pricing with no hidden fees, dose-ladder upsells, or surprise billing. Whether you start with the Microdose GLP-1 Protocol at $129 per month or jump to compounded tirzepatide injections at $249 per month, that price remains stable as your clinician adjusts your dose upward toward therapeutic effect. This contrasts sharply with some telemedicine platforms that increase monthly fees as patients escalate doses, creating financial stress during the critical phase when treatment becomes most effective.

All medications are shipped directly to patients in all 50 states within 5–7 business days, with no membership or subscription lock-ins. Patients can pause, switch compounds, or modify their protocol without contractual penalties, giving them control over their healthcare journey and spending.

The $99 Precision Peptide Genetic Test is optional but recommended for patients aiming for long-term success, as it eliminates guesswork about which medication will work best for their unique biology. PlexusDx recommends testing after the first month of initial therapy, allowing patients to confirm tolerability before investing in genetic-guided optimization.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much cheaper is PlexusDx compounded semaglutide compared to Wegovy?

PlexusDx compounded semaglutide starts at $149 per month versus Wegovy's typical $900–$1,500 monthly cost, representing a savings of approximately 80% for most patients. Over 12 months, this difference equals $10,000–$15,800 in savings while maintaining the same active ingredient and therapeutic outcomes from licensed 503A compounding pharmacies.

Does PlexusDx pricing go up as my dose increases?

No. PlexusDx uses flat-rate pricing regardless of dose escalation—your dose may need to go up, but your price won't. A patient starting at 0.25 mg semaglutide and escalating to 2.4 mg pays the same $149 per month throughout their treatment journey.

Why should I consider genetic testing if my GLP-1 treatment is already working?

Genetic testing through PlexusDx Precision Peptide Genetic Test ($99) identifies whether you're on the optimal compound for your biology. Even if your current medication works, genetic insights may reveal that tirzepatide or a dual-compound approach could deliver faster results, allow lower doses, or reduce side effects—maximizing both outcomes and cost-efficiency.

Can I use insurance with PlexusDx compounded medications?

PlexusDx requires no insurance and functions as a self-pay service available in all 50 states. However, compounded medications are HSA and FSA eligible, allowing patients to use tax-advantaged health savings accounts to reduce their actual out-of-pocket cost. Some patients find self-pay through HSA/FSA more affordable than navigating insurance denials or non-coverage of weight loss medications.

What genetic variants does the Precision Peptide Genetic Test analyze?

PlexusDx Precision Peptide Genetic Test examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313, mapping 14 metabolic pathways and 49 peptides to generate 150+ personalized insights. These variants predict how your body will respond to semaglutide, tirzepatide, and other peptide-based therapies, guiding optimal medication selection.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves